000			02153nam a22002417a 4500
003			OSt
005			20240305193735.0
008			221123b |||||||| |||| 00| 0 eng d
028			_b Phone: +255 28 298 3384
028			_b Fax: +255 28 298 3386
028			_b Email: vc@bugando.ac.tz
028			_b Website: www.bugando.ac.tz
040			_bEnglish _cDLC
041			_aEnglish
100			_aStephen E Mshana _915820
245			_a21 Urinary tract infections in Tanzania: diagnosis, pathogens and susceptibility pattern
260			_aMwanza, Tanzania: _bGlobal Health & _b Catholic University of Health and Allied Sciences [CUHAS – Bugando] _c2012
300			_a Pages 245
490			_vGlobal Health
520			_aTanzania is one of the sub-Saharan African countries most affected by bacterial infectious diseases. Communicable diseases dominate the pattern of overall morbidity and contribute to over 49% of the total burden of diseases [1]. Irrational drug use as well as the presence of counterfeit drugs on the local market has been shown to be the main factors in the emergence of multi drug resistance (MDR) bacteria. Worldwide, more than 50% of all medicines are prescribed, dispensed or sold inappropriately, and 50% of all patients fail to take them correctly [2]. As a consequence, the prevalence of antimicrobial resistances is an emerging threat, with resistances of up to 70-90% to original first-line antibiotics [2]. In Tanzania, high prevalence of nosocomial infections caused by Klebsiella pneumonia, Escherichia coli and Staphylococcus aureus has been reported in tertiary hospitals affecting many departments especially, Intensive Care Unit (ICU), postoperative, burned, and pediatric patients [3, 4, 5]. Studies in Tanzania have documented a high prevalence of ESBL in tertiary hospitals. Prevalence of ESBL at the Muhimbili National Hospital (MNH) is about 40%[6]. At the Bugando Medical Centre (BMC), prevalence is 25% for Escherichia coli and 50% for Klebsiella pneumonia [4].
856			_uhttps://library.oapen.org/bitstream/handle/20.500.12657/32569/610281.pdf?sequence=1#page=251
942			_2ddc _cVM
999			_c19657 _d19657